3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4997 out of 5168 analysts
Average Return
-1.1%
Win Rate
37%205 out of 547
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +776.87% | $1.34 | $11.75 | 2025-04-14 - 2026-01-09 | Buy |
Cogent Biosciences IncCOGT | +565.73% | $5.31 | $35.35 | 2025-05-20 - 2026-01-09 | Buy |
Cogent Biosciences IncCOGT | +379.65% | $7.37 | $35.35 | 2025-01-14 - 2026-01-09 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Prelude Therapeutics IncPRLD | +330.44% | $0.61 | $2.63 | 2025-04-08 - 2026-01-09 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tuhura Biosciences IncHURA | 4 | Buy | $10.00 | +1,226.26% | Reiterates | 2 days ago |
Cullinan Therapeutics IncCGEM | 4 | Buy | $27.00 | +147.71% | Maintains | 3 days ago |
Exelixis IncEXEL | 12 | Buy | $52.00 | +18.07% | Maintains | 3 days ago |
Cogent Biosciences IncCOGT | 15 | Buy | $52.00 | +47.10% | Maintains | 5 days ago |
Telix Pharmaceuticals LtdTLX | 3 | Buy | $20.00 | +164.55% | Reiterates | 20 days ago |
Nuvation Bio IncNUVB | 17 | Buy | $18.00 | +123.88% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 20 | Buy | $31.00 | +60.62% | Maintains | a month ago |
IMMIX Biopharma IncIMMX | 10 | Buy | $12.00 | +146.41% | Maintains | a month ago |
Zymeworks IncZYME | 23 | Buy | $32.00 | +38.11% | Maintains | 2 months ago |
Oric Pharmaceuticals IncORIC | 26 | Buy | $23.00 | +151.37% | Maintains | 2 months ago |
Biontech SeBNTX | 44 | Buy | $140.00 | +40.21% | Maintains | 2 months ago |
Adicet Bio IncACET | 2 | Buy | $144.00 | +1,693.28% | Maintains | 2 months ago |
Revolution Medicines IncRVMD | 19 | Buy | $73.00 | -38.47% | Maintains | 2 months ago |
Caribou Biosciences IncCRBU | 15 | Buy | $9.00 | +442.17% | Maintains | 2 months ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | +9.29% | Reiterates | 2 months ago |
Fate Therapeutics IncFATE | 7 | Buy | $5.00 | +376.19% | Upgrades | 2 months ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | +18.11% | Maintains | 2 months ago |
Replimune Group IncREPL | 17 | Buy | $12.00 | +49.44% | Upgrades | 2 months ago |
Bolt Biotherapeutics IncBOLT | 1 | Buy | $7.00 | +20.07% | Assumes | 3 months ago |
Adc Therapeutics SaADCT | 19 | Buy | $7.00 | +91.26% | Maintains | 3 months ago |
Karyopharm Therapeutics IncKPTI | 2 | Buy | $15.00 | +72.81% | Upgrades | 3 months ago |
Perspective Therapeutics IncCATX | 5 | Buy | $10.00 | +252.11% | Reiterates | 3 months ago |
Prelude Therapeutics IncPRLD | 17 | Buy | $5.00 | +90.11% | Reiterates | 4 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $27.00 | +104.70% | Initiates Coverage On | 4 months ago |
Onkure Therapeutics IncOKUR | 4 | Buy | $34.00 | +982.80% | Reiterates | 5 months ago |
Relay Therapeutics IncRLAY | 21 | Buy | $14.00 | +75.22% | Maintains | 5 months ago |
Bicara Therapeutics IncBCAX | 5 | Buy | $40.00 | +122.84% | Maintains | 5 months ago |
Arrivent Biopharma IncAVBP | 11 | Buy | $42.00 | +104.68% | Maintains | 5 months ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +255.87% | Maintains | 5 months ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | -0.12% | Downgrades | 5 months ago |
Cardiff Oncology IncCRDF | 3 | Buy | $10.00 | +224.68% | Maintains | 5 months ago |
Elicio Therapeutics IncELTX | 8 | Buy | $13.00 | +61.29% | Maintains | 6 months ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +84.62% | Maintains | 6 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 8 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +10.64% | Reiterates | 9 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +323.73% | Reiterates | 10 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +367.84% | Maintains | 10 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | N/A | Reiterates | a year ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 3 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 5 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.